MiRNA expression deregulation correlates with the Oncotype DX® DCIS score

MiRNA expression deregulation correlates with the Oncotype DX® DCIS score

Abstract Background Current clinical criteria do not discriminate well between women who will or those who will not develop ipsilateral invasive breast cancer (IBC), or a DCIS recurrence after a ductal carcinoma in situ (DCIS) diagnosis. The 12-gene Oncotype DX® DCIS assay (RT qPCR gene-based scorin...

Full description

Bibliographic Details
Main Authors: Olivier Loudig, Megan I. Mitchell, Iddo Z. Ben-Dov, Christina Liu, Susan Fineberg
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Breast Cancer Research
Online Access:https://doi.org/10.1186/s13058-022-01558-4

Internet

https://doi.org/10.1186/s13058-022-01558-4

Similar Items